Shire Says Baxalta Combination to Boost Profit; Stock Surges

Updated on
  • Baxalta deal to deliver $700 million in savings over 3 years
  • EPS likely to grow to $12.70-$13.10 this year, Shire says

Shire Plc said the $32 billion takeover of U.S. drugmaker Baxalta Inc. will boost earnings and sales this year, sending its stock surging to the highest level in almost a year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.